Vetoquinol S.A [VETO] vs Ipsen S.A [IPN] Detailed Stock Comparison

Vetoquinol S.A

Euronext
Loading...

Ipsen S.A

Euronext
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Vetoquinol S.A wins in 6 metrics, Ipsen S.A wins in 12 metrics, with 0 ties. Ipsen S.A appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricVetoquinol S.AIpsen S.ABetter
P/E Ratio (TTM)16.0821.58Vetoquinol S.A
Price-to-Book Ratio1.642.27Vetoquinol S.A
Debt-to-Equity Ratio3.6722.74Vetoquinol S.A
PEG RatioN/A11.44N/A
EV/EBITDA6.846.77Ipsen S.A
Profit Margin (TTM)10.88%11.91%Ipsen S.A
Operating Margin (TTM)16.28%26.17%Ipsen S.A
EBITDA Margin (TTM)16.28%26.17%Ipsen S.A
Return on Equity10.64%10.89%Ipsen S.A
Return on Assets (TTM)6.66%9.58%Ipsen S.A
Free Cash Flow (TTM)$68.15M$133.00MIpsen S.A
Dividend Yield1.27%1.38%Ipsen S.A
1-Year Return-9.83%2.06%Ipsen S.A
Price-to-Sales Ratio (TTM)1.792.55Vetoquinol S.A
Enterprise Value$675.97M$9.02BIpsen S.A
EV/Revenue Ratio1.252.40Vetoquinol S.A
Revenue per Share (TTM)$46$45Vetoquinol S.A
Earnings per Share (Diluted)$4.98$5.37Ipsen S.A
Beta (Stock Volatility)0.750.19Ipsen S.A
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Vetoquinol S.A vs Ipsen S.A Stock Performance Analysis

Loading Price Chart...

Vetoquinol S.A
Ipsen S.A
Vetoquinol S.A Stock Overview | Ipsen S.A Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Vetoquinol S.A-1.55%-4.99%2.84%6.28%-9.19%0.13%
Ipsen S.A-1.81%-2.57%-1.47%12.90%4.31%0.62%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Vetoquinol S.A-9.83%-4.88%4.25%87.76%235.24%235.24%
Ipsen S.A2.06%19.92%33.57%101.17%448.70%448.70%

News Based Sentiment: Vetoquinol S.A vs Ipsen S.A

Vetoquinol S.A

News based Sentiment: POSITIVE

Vetoquinol demonstrated resilience in H1 2025 by maintaining profitability and a strong cash position despite a slight sales decline. The positive market reaction and continued analyst confidence suggest investors are optimistic about the company’s long-term prospects, making it a stable investment opportunity.

View Vetoquinol S.A News Sentiment Analysis

Ipsen S.A

News based Sentiment: POSITIVE

September was a strong month for Ipsen, marked by significant regulatory approvals for Bylvay in both Canada and Japan, positive Phase II data for a promising new aesthetic product (IPN10200), and continued share buybacks. These developments, combined with optimistic financial guidance, suggest a positive trajectory for the company and strengthen the investment case.

View Ipsen S.A News Sentiment Analysis

Performance & Financial Health Analysis: Vetoquinol S.A vs Ipsen S.A

MetricVETOIPN
Market Information
Market Cap i€951.66M€9.52B
Market Cap CategoryMid capLarge cap
10 Day Avg. Volume i7,83777,379
90 Day Avg. Volume i4,22573,135
Last Close€76.10€113.80
52 Week Range€63.60 - €87.70€87.95 - €125.60
% from 52W High-13.23%-9.39%
All-Time High€161.00 (Nov 01, 2021)€155.95 (Sep 10, 2018)
% from All-Time High-52.73%-27.03%
Growth Metrics
Quarterly Revenue Growth0.01%0.11%
Quarterly Earnings Growth0.50%0.44%
Financial Health
Profit Margin (TTM) i0.11%0.12%
Operating Margin (TTM) i0.16%0.26%
Return on Equity (TTM) i0.11%0.11%
Debt to Equity (MRQ) i3.6722.74
Cash & Liquidity
Book Value per Share (MRQ)€48.82€51.15
Cash per Share (MRQ)€17.49€17.50
Operating Cash Flow (TTM) i€85.83M€976.20M
Levered Free Cash Flow (TTM) i€61.39M€468.82M
Dividends
Last 12-Month Dividend Yield i1.27%1.38%
Last 12-Month Dividend i€0.89€1.40

Valuation & Enterprise Metrics Analysis: Vetoquinol S.A vs Ipsen S.A

MetricVETOIPN
Price Ratios
P/E Ratio (TTM) i16.0821.58
Forward P/E i14.8311.44
PEG Ratio iN/A11.44
Price to Sales (TTM) i1.792.55
Price to Book (MRQ) i1.642.27
Market Capitalization
Market Capitalization i€951.66M€9.52B
Enterprise Value i€675.97M€9.02B
Enterprise Value Metrics
Enterprise to Revenue i1.252.40
Enterprise to EBITDA i6.846.77
Risk & Other Metrics
Beta i0.750.19
Book Value per Share (MRQ) i€48.82€51.15

Financial Statements Comparison: Vetoquinol S.A vs Ipsen S.A

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)VETOIPN
Revenue/Sales iN/AN/A
Cost of Goods Sold iN/AN/A
Gross Profit iN/AN/A
Research & Development iN/AN/A
Operating Income (EBIT) iN/AN/A
EBITDA iN/AN/A
Pre-Tax Income iN/AN/A
Income Tax iN/AN/A
Net Income (Profit) iN/AN/A

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)VETOIPN
Cash & Equivalents i€206.33M€1.45B
Total Current Assets i€421.18M€2.81B
Total Current Liabilities i€141.53M€1.42B
Long-Term Debt i€11.22M€835.60M
Total Shareholders Equity i€575.93M€4.23B
Retained Earnings i€58.69M€334.00M
Property, Plant & Equipment i€17.79M€478.90M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)VETOIPN
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricVETOIPN
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i7,83777,379
Average Daily Volume (90 Day) i4,22573,135
Shares Outstanding i11.80M82.71M
Float Shares i3.83M25.15M
% Held by Insiders i0.67%0.57%
% Held by Institutions i0.12%0.15%

Dividend Analysis & Yield Comparison: Vetoquinol S.A vs Ipsen S.A

MetricVETOIPN
Last 12-Month Dividend i€0.89€1.40
Last 12-Month Dividend Yield i1.27%1.38%
3-Year Avg Annual Dividend i€0.85€1.27
3-Year Avg Dividend Yield i0.99%1.14%
3-Year Total Dividends i€2.54€3.80
Ex-Dividend DateJun 04, 2025Jun 04, 2025